{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:35:52Z","timestamp":1787322952170,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"DOI":"10.7759\/cureus.114926","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:35:29Z","timestamp":1787319329000},"source":"Crossref","is-referenced-by-count":0,"title":["Adjunct Corticosteroids in Children With Community-Acquired Pneumonia Presenting to the Emergency Department: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Sarra Elnour","family":"Ahmed Elnour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meshari","family":"Dalbouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana Gasmelsaid","family":"Almamoun Gamaraldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Hamed","family":"Hag Elzain Eltoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna Omer","family":"Abdelgayoum Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyseer Hassan","family":"Abdelgadie Abdelhafeez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"GasmElseed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley JS","year":"2011","unstructured":"Bradley JS, Byington CL, Shah SS, et al.. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011, 53:e25-76. 10.1093\/cid\/cir531","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien KL","year":"2009","unstructured":"O'Brien KL, Wolfson LJ, Watt JP, et al.. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009, 374:893-902. 10.1016\/S0140-6736(09)61204-6","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Meijvis SC","year":"2011","unstructured":"Meijvis SC, Hardeman H, Remmelts HH, et al.. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011, 377:2023-30. 10.1016\/S0140-6736(11)60607-7","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum CA","year":"2015","unstructured":"Blum CA, Nigro N, Briel M, et al.. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2015, 385:1511-8. 10.1016\/S0140-6736(14)62447-8","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1457469","article-title":"The effect and safety of corticosteroid treatment for severe community-acquired pneumonia: a meta-analysis of randomized controlled trials","volume":"11","author":"Chen Y","year":"2024","unstructured":"Chen Y, Kuang H, Zhu Y, Luo X. The effect and safety of corticosteroid treatment for severe community-acquired pneumonia: a meta-analysis of randomized controlled trials. Front Med (Lausanne). 2024, 11:1457469. 10.3389\/fmed.2024.1457469","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial","volume":"313","author":"Torres A","year":"2015","unstructured":"Torres A, Sibila O, Ferrer M, et al.. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015, 313:677-86. 10.1001\/jama.2015.88","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin PF","year":"2023","unstructured":"Dequin PF, Meziani F, Quenot JP, et al.. Hydrocortisone in severe community-acquired pneumonia. N Engl J Med. 2023, 388:1931-41. 10.1056\/NEJMoa2215145","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-0983","article-title":"Adjunct corticosteroids in children hospitalized with community-acquired pneumonia","volume":"127","author":"Weiss AK","year":"2011","unstructured":"Weiss AK, Hall M, Lee GE, Kronman MP, Sheffler-Collins S, Shah SS. Adjunct corticosteroids in children hospitalized with community-acquired pneumonia. Pediatrics. 2011, 127:e255-63. 10.1542\/peds.2010-0983","journal-title":"Pediatrics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piu017","article-title":"Adjunct systemic corticosteroid therapy in children with community-acquired pneumonia in the outpatient setting","volume":"4","author":"Ambroggio L","year":"2015","unstructured":"Ambroggio L, Test M, Metlay JP, Graf TR, Blosky MA, Macaluso M, Shah SS. Adjunct systemic corticosteroid therapy in children with community-acquired pneumonia in the outpatient setting. J Pediatric Infect Dis Soc. 2015, 4:21-7. 10.1093\/jpids\/piu017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan X","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014, 14:135. 10.1186\/1471-2288-14-135","journal-title":"BMC Med Res Methodol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris CR","year":"2020","unstructured":"Harris CR, Millman KJ, van der Walt SJ, et al.. Array programming with NumPy. Nature. 2020, 585:357-62. 10.1038\/s41586-020-2649-2","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22574","article-title":"Efficacy of methylprednisolone in children with severe community acquired pneumonia","volume":"48","author":"Nagy B","year":"2013","unstructured":"Nagy B, Gaspar I, Papp A, Bene Z, Nagy B Jr, Voko Z, Balla G. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatr Pulmonol. 2013, 48:168-75. 10.1002\/ppul.22574","journal-title":"Pediatr Pulmonol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.02.043","article-title":"Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial","volume":"185","author":"Tagarro A","year":"2017","unstructured":"Tagarro A, Otheo E, Baquero-Artigao F, et al.. Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial. J Pediatr. 2017, 185:117-123.e6. 10.1016\/j.jpeds.2017.02.043","journal-title":"J Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2025-328990","article-title":"Outcome of early short course corticosteroid therapy in severe community-acquired pneumonia: a randomised controlled trial","volume":"111","author":"Singh A","year":"2026","unstructured":"Singh A, Biswal N, DelhiKumar CG, Bobby Z, Nair NS. Outcome of early short course corticosteroid therapy in severe community-acquired pneumonia: a randomised controlled trial. Arch Dis Child. 2026, 111:697-702. 10.1136\/archdischild-2025-328990","journal-title":"Arch Dis Child"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154507","article-title":"Efficacy and safety of corticosteroids for the treatment of community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials","volume":"80","author":"Cheema HA","year":"2024","unstructured":"Cheema HA, Musheer A, Ejaz A, et al.. Efficacy and safety of corticosteroids for the treatment of community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials. J Crit Care. 2024, 80:154507. 10.1016\/j.jcrc.2023.154507","journal-title":"J Crit Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0000000000002984","article-title":"Impact of adjunct corticosteroid therapy on quality of life for children with suspected pneumonia","volume":"39","author":"Navanandan N","year":"2023","unstructured":"Navanandan N, Florin TA, Leonard J, et al.. Impact of adjunct corticosteroid therapy on quality of life for children with suspected pneumonia. Pediatr Emerg Care. 2023, 39:482-7. 10.1097\/PEC.0000000000002984","journal-title":"Pediatr Emerg Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/520253-adjunct-corticosteroids-in-children-with-community-acquired-pneumonia-presenting-to-the-emergency-department-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:35:30Z","timestamp":1787319330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/520253-adjunct-corticosteroids-in-children-with-community-acquired-pneumonia-presenting-to-the-emergency-department-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.114926","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}